
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & Podcasts
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease is an episode from FDA Drug Information Updates by ReachMD. FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disea...
This episode belongs to FDA Drug Information Updates.
Use the player on this page to stream the episode online.
Published Aug 17, 2017, 00:05:29 long, audio available.
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017
You can listen to FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease online on Radio and Podcast. Open the player on this page to stream the available audio.
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease is an episode from FDA Drug Information Updates by ReachMD.
This episode is 00:05:29 long.
This episode was published on Aug 17, 2017.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.